Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Meghen B. Browning MD
Assistant Professor
Department of Pediatrics
Division of Hematology/Oncology

OFFICE ADDRESS:
MACC Fund Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226
Phone: 414-955-4628
Fax: 414-456-6543

CITIZENSHIP:  United States

EDUCATION:
1986 - 1990 BA, Macalester College, St. Paul, MN
1990 - 1995 MD, University of Missouri-Columbia School of Medicine (cum laude), Columbia, MO

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1995 - 1998 Residency, Pediatrics, Medical College of Wisconsin, Milwaukee, WI
2000 - 2003 Fellowship, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI
2003 - 2004 Research Fellowship, Pediatrics, Bone Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI

FACULTY APPOINTMENTS:
2004 - Present Assistant Professor, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, WI

ADMINISTRATIVE APPOINTMENTS:
1998 - 2000 Medical Officer, Public Health Service, Navajo Nation, Chinle, AZ

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
2007 - Present Director, Pediatrics, Musculoskeletal Oncology Program, Children's Hospital of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
2000 - Present Staff Physician, Pediatrics, Hematology/Oncology/BMT, Children's Hospital of Wisconsin, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Pediatrics
10/1999
None
American Board of Pediatrics, Hematology-Oncology
10/2004
None
 
Licensure
Number Issue DateExpiration
Medical License
37958-20
7/1996
10/31/2015
 
AWARDS AND HONORS:
3/1998 First place, Resident Research Day
2003 - 2004 One of 20 fellows and junior faculty from across the US and Canada selected on a competitive basis for participation in the first year of this training and mentoring program, American Society of Hematology’s Clinical Research Training Institute (ASH- CRTI)

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
American Academy of Pediatrics (Member)
Children's Oncology Group (Member)
American Society of Hematology (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
Journal of Pediatric Hematology/Oncology
Ophthalmic Plastic & Reconstructive Surgery

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
Co-Chair, Logistics Committee, Children's Oncology Group (COG)
Member, Neuroblastoma Committee: High-risk Protocol Consolidation Task Force, Children's Oncology Group (COG)

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Preclinical Study to Optimize Anti-tumor Immune Activation Against Breast Cancer and Multiple Myeloma Using Tumor Vaccination in Combination with Lymphodepletion and Immune Modulating Agents
Source:
Clinical and Translational Science Institute (CTSI)
Role:
Co-Investigator
PI:
Jill Gershan
Dates:
2011 - 2013
Direct Funds:
$50,000
 
Title:
Cellular and Adoptive Immunotherapy using Hematopoietic Cell Transplantation and NK Cell Infusion for the Treatment of High-Risk Pediatric and Adult Solid Tumors: a Phase I/II Study
Source:
Clinical and Translational Science Institute (CTSI)
Role:
Co-Investigator
PI:
Monica Thakar/Subramaniam Malarkannan
Dates:
7/1/2012 - 6/30/2013
Direct Funds:
$50,000
 
Title:
Use of a Power Hickman for Peripheral Blood Stem Cell Collection in Pediatric Patients
Source:
Unfunded; data submitted to QHS team and is in the process of being reviewed
Role:
Co-Investigator, Sr. Investigator
PI:
Mollie Haddigan-Mulberry
 
Title:
MTP-OS-403 - actively enrolling patients to study the compassionate use study allowing the use of liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine for recurrent osteosarcoma patients
Source:
Millennium Pharmaceuticals
Role:
Local PI
 
Title:
Pain Study - goal of this study is to develop a data-based recommendation for initiation of pain control in the post-operative period for bone tumor patients
Source:
Unfunded; recently IRB approved, feasibility analysis pending
Role:
Co-Principal Investigator
PI:
David King/Meg Browning
 
Pending
Peer Review
Title:
Gender Study - goal of this study is to link tumor necrosis to gender-based outcome inequality in patients with primary bone tumors
Source:
Unfunded; data collection in progress
Role:
Co-Principle Investigator
PI:
David King/Meg Browning
 
Prior
Peer Review
Title:
Ruth L. Kirschstein National Research Service Award (NRSA)
Source:
NIH
Dates:
6/28/2003 - 6/27/2005
 
Title:
Vaccine Responses and the Effect of Chemotherapy
Source:
MACC Fund Research Grant
Role:
PI
Dates:
7/1/2008 - 6/30/2009
Direct Funds:
$40,000
 
INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
1. Invited Speaker, The Laboratory and Bone Marrow Transplants, Milwaukee Society for Clinical Laboratory Science, Milwaukee, WI, 10/2003
 
Regional
1. Invited Speaker, Pediatric Bone Tumors, Northwestern Lake Forest Hospital, Grayslake, IL, 7/2008
 
PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
1. Browning MB, Baylerian DM, Johnson ST, Gottschall, JL, Positive direct antiglobulin tests in a pediatric population, American Society of Hematology (ASH) 44th Annual Meeting - Poster Presentation, Orlando, FL, 12/2001
2. Browning MB, Kugathasan S, Casper JT, Margolis DA, Infliximab for chronic GVHD in pediatric patients, American Society of Hematology (ASH) 45th Annual Meeting - Poster Presentation, Philadelphia, PA, 12/2002
3. Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD, The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells, Tandem Bone Marrow Transplant Meeting - Poster Presentation, Keystone, CO, 1/2003
4. Keever-Taylor CA, Browning MB, Johnson BD, Behn B, Truitt, RL, Optimization of culture methods for the expansion of CD4+CD25+ regulatory t cells for potential clinical use, Tandem Bone Marrow Transplant Meeting (Combined ASBMT and IBMTR/ABMTR Annual Meetings) - Poster Presentation, New Orleans, LA, 1/2005
 
COMMITTEE SERVICE:
Hospital
2003 - Present Interviewer, Intern Selection Committee, Children's Hospital of Wisconsin
2008 - Present Subcommittee Member, COG Neuroblastoma Group, Children's Oncology Group
2008 Chair, Inpatient Planning Committee, Pediatrics, Children's Hospital of Wisconsin
2011 Co-Leader, Collaborative Practice Guidelines Committee, Children's Hospital of Wisconsin
 
MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
2010 - Present Clinical Mentor for M-1 Students
Facilitator for Professionalism Course
 
Resident and Fellow Education
3/1998 Resident Research Day Presentation - Age-Related Changes in the Human T cell Receptor Repertoire
2000 - Present Ward attending/teacher for Oncology fellows and residents 8 weeks/year (average)
2003 - 2005 Facilitator for Biochemistry Clinical Correlation Sessions
2004 - 2011 3 lectures/month (average) for Oncology Residents
2006 - Present Clinic Supervisor for Oncology Fellow
2007 - Present 2 lectures/year (average) for Oncology Fellows
Supervise fellow for periodic Tumor Board presentations
 
Continuing Medical Education
9/2005 Grand Rounds Presentation - Leukemia and Lymphoma
8/2008 Organized speaker visit for Musculoskeletal Oncology program; included clinic visits, Grand Rounds, Children’s Research Institute talk
 
Postdoctoral Fellow Education
2005 - 2007 Clinical Mentor for Medical Scientist Training Program MD-PhD student
 
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Medical College of Wisconsin, 2005 - 2007 Clinical Mentor for Medical Scientist Training Program
 
Clinical/Research Fellows
Medical College of Wisconsin, 2006 - Present Oncology Clinic Supervisor
 
CAREER DEVELOPMENT:
2011 Initiated Performance Improvement Module, “Safe Prescription and Medication Order Writing” through the ABP as component of maintenance of certification
2011 Participated in day-long workshop presented by Rank and Tenure committee to better prepare for career advancement.


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Browning MB, Camitta BM. The surgeon's role in pediatric orbital malignancies: an oncologist's perspective. Ophthal Plast Reconstr Surg. 2003 Sep;19(5):340-4.
2. Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD. The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. Cell Immunol. 2004 Feb;227(2):129-39.
3. Keever-Taylor CA, Browning MB, Johnson BD, Truitt RL, Bredeson CN, Behn B, Tsao A. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. Cytotherapy. 2007;9(2):144-57.
4. Maronn M, Catrine K, North P, Browning MB, Kerschner JE, Noel R, Drolet BA, Kelly M. Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia. Pediatr Blood Cancer. 2009 Apr;52(4):531-4.
5. Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD. The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. Cell Immunol. 2004 Feb;227(2):129-39.
6. Browning M, Mortland L, Malogolowkin M. Chemotherapy in pediatric bone and soft tissue sarcomas. In Current Orthopaedic Practice. Volume 24, Number 3. May/June 2013.
 
Books, Chapters, and Reviews
1. Browning M, Mortland L, Malogolowkin M. Chemotherapy in pediatric bone and soft tissue sarcomas. In Current Orthopaedic Practice. Editor Arkader A. Lippincott Williams & Wilkins. Accepted in print 2013.
 
Abstracts
1. Browning MB, Baylerian DM, Johnson ST, Gottschall, JL. Positive direct antiglobulin tests in a pediatric population. Blood (American Society of Hematology Meeting Abstracts). 2001 Nov 16;98(11 Pt 1):1a-953a.
2. Browning MB, Kugathasan S, Casper JT, Margolis DA. Infliximab for chronic GVHD in pediatric patients. Blood (American Society of Hematology Meeting Abstracts). 2001 Nov 16;98(11 Pt 1):1a-953a.
3. Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD. The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. Biol Blood Marrow Tr. 2003 Feb;09(suppl).
4. Keever-Taylor CA, Browning MB, Johnson BD, Behn B, Truitt RL. Optimization of culture methods for the expansion of CD4+CD25+ regulatory T cells for potential clinical use. Biol Blood Marrow Tr. 2005 Feb; 11(2) Suppl 1:44.